Phillips Jack's Form 4 filing
Accelerate Diagnostics, Inc (AXDX) · filed Apr 7, 2025
- Accession no.
- 0001104659-25-032762
- Filed
- Apr 7, 2025
- Trade date
- Apr 4, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $16.5K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Phillips JackCIK 0001784805 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2025 | Common Stock | MOption exerciseAcquired | +53,283 | $0.00F1 | $0 | 216,717 | Direct | |
| Apr 4, 2025 | Common Stock | SSaleDisposed | −25,343 | $0.65 | −$16,472.95 | 191,374 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2025 | Common Stock | MOption exerciseDisposed | −53,283 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
Referenced by the price of 1 transaction in Table I.